#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA703726	F	Drug concentration in mole/kg/day providing 50% extension of life in intraperitoneally implanted leukemia L1210 mice.	Mus musculus	771		cell-based format	Scientific Literature
2.	ALA813896	A	Compound concentration in mole/kg/day lethal to 10% of mice	Mus sp.	771		organism-based format	Scientific Literature
3.	ALA5051789	F	Antiproliferative activity against human MDA-MB-231 cells at 2 uM assessed as induction of cells death and measured after 24 hrs by Cell Titer Blue assay relative to control	Homo sapiens	1		cell-based format	Patent Bioactivity Data
4.	ALA5051790	F	Antiproliferative activity against human HeLa cells transfected with LY6K-shRNA2 assessed as fold increase in cell death and measured by Cell Titer Blue assay	Homo sapiens	1		cell-based format	Patent Bioactivity Data
5.	ALA5051791	F	Antiproliferative activity against human MDA-MB-231 cells transfected with LY6K-ShRNA2 at 2 uM assessed as induction of cells death and measured after 24 hrs by Cell Titer Blue assay relative to control	Homo sapiens	1		cell-based format	Patent Bioactivity Data
6.	ALA5051792	F	Antiproliferative activity against human MDA-MB-231 cells after 24 hrs by Cell Titer Blue assay	Homo sapiens	1		cell-based format	Patent Bioactivity Data
7.	ALA5051793	F	Antiproliferative activity against human Hs-578T cells after 24 hrs by Cell Titer Blue assay	Homo sapiens	1		cell-based format	Patent Bioactivity Data
8.	ALA5051794	F	Antiproliferative activity against human BT-549 cells after 24 hrs by Cell Titer Blue assay	Homo sapiens	1		cell-based format	Patent Bioactivity Data
9.	ALA5051795	F	Antiproliferative activity against human OVCAR-8 cells after 24 hrs by Cell Titer Blue assay	Homo sapiens	1		cell-based format	Patent Bioactivity Data
10.	ALA5051796	F	Antitumor activity against mouse 4T1 cells allografted in syngenetic BALB/c mouse assessed as tumor growth inhibition at 5 mg/kg, IT(Intratumoral) measured at day 3	Mus musculus	1		organism-based format	Patent Bioactivity Data
11.	ALA5051798	F	Antitumor immunity in C57BL/6 mouse xenografted with mouse EO771 cells assessed as reduction in tumor growth at 10 mg/kg, ip administered every 3rd day	Mus musculus	1		organism-based format	Patent Bioactivity Data
12.	ALA5051801	F	Down-regulation of PD-L1 expression in human MDA-MB-231 cells at 2 uM measured after 30 mins by Western blot analysis	Homo sapiens	2		cell-based format	Patent Bioactivity Data
13.	ALA5051802	B	Inhibition of TGF-beta1-induced Smad2/3 phopshorylation in human MDA-MB-231 cells at 2 uM measured after 30 mins by Western blot analysis	Homo sapiens	2		cell-based format	Patent Bioactivity Data
14.	ALA5051803	B	Inhibition of IFN-gamma-induced Stat1 phopshorylation in human MDA-MB-231 cells at 2 uM measured after 30 mins by Western blot analysis	Homo sapiens	2		cell-based format	Patent Bioactivity Data
15.	ALA5051804	F	Antitumor activity against mouse 4T1 cells xenografted mouse assessed as decrease in Cd11b and Gr-1-dual positive lymphocytes in peripheral blood at 50 mg/kg, iv	Mus musculus	1		organism-based format	Patent Bioactivity Data
16.	ALA5051805	F	Antitumor activity against mouse 4T1 cells xenografted mouse assessed as decrease in myeloid-derived suppressor cells (MDSCs) in peripheral blood at 50 mg/kg, iv	Mus musculus	1		organism-based format	Patent Bioactivity Data
17.	ALA5051806	F	Cell cycle arrest in mouse 4T1 cells assessed as accumulation at sub G1 phase at 1 uM (Rvb = 0.4%)	Mus musculus	1		cell-based format	Patent Bioactivity Data
18.	ALA5051807	F	Cell cycle arrest in mouse 4T1 cells assessed as accumulation at G1 phase at 1 uM (Rvb = 58.1%)	Mus musculus	1		cell-based format	Patent Bioactivity Data
19.	ALA5051808	F	Cell cycle arrest in mouse 4T1 cells assessed as accumulation at S phase at 1 uM (Rvb = 18.8%)	Mus musculus	1		cell-based format	Patent Bioactivity Data
20.	ALA5051809	F	Cell cycle arrest in mouse 4T1 cells assessed as accumulation at G2 phase at 1 uM (Rvb = 22.7%)	Mus musculus	1		cell-based format	Patent Bioactivity Data